These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10073443)

  • 1. Skin sensitization risk assessment: a comparative evaluation of 3 isothiazolinone biocides.
    Basketter DA; Rodford R; Kimber I; Smith I; Wahlberg JE
    Contact Dermatitis; 1999 Mar; 40(3):150-4. PubMed ID: 10073443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of application vehicle on skin sensitization to methylchloroisothiazolinone/methylisothiazolinone: an analysis using the local lymph node assay.
    Warbrick EV; Dearman RJ; Basketter DA; Kimber I
    Contact Dermatitis; 1999 Dec; 41(6):325-9. PubMed ID: 10617213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
    Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
    Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data.
    Griem P; Goebel C; Scheffler H
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):269-90. PubMed ID: 14623479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between experimental human and murine skin sensitization induction thresholds.
    Api AM; Basketter D; Lalko J
    Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive identification of human skin sensitization thresholds.
    Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
    Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregate consumer exposure to isothiazolinones via household care and personal care products: Probabilistic modelling and benzisothiazolinone risk assessment.
    Garcia-Hidalgo E; Schneider D; von Goetz N; Delmaar C; Siegrist M; Hungerbühler K
    Environ Int; 2018 Sep; 118():245-256. PubMed ID: 29894934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isothiazolinone derivatives and allergic contact dermatitis: a review and update.
    Herman A; Aerts O; de Montjoye L; Tromme I; Goossens A; Baeck M
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):267-276. PubMed ID: 30284765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
    Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
    Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airborne allergic contact dermatitis caused by isothiazolinones in water-based paints: a retrospective study of 44 cases.
    Amsler E; Aerts O; Raison-Peyron N; Debons M; Milpied B; Giordano-Labadie F; Waton J; Ferrier-Le Bouëdec MC; Lartigau I; Pecquet C; Assier H; Avenel-Audran M; Bernier C; Castelain F; Collet E; Crépy MN; Genillier N; Girardin P; Pralong P; Tetart F; Vital-Durand D; Soria A; Barbaud A;
    Contact Dermatitis; 2017 Sep; 77(3):163-170. PubMed ID: 28449346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational allergic contact dermatitis from 1,2-benzisothiazolin-3-one without cross-sensitization to other isothiazolinones.
    Muhn C; Sasseville D
    Contact Dermatitis; 2003 Apr; 48(4):230-1. PubMed ID: 12786737
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk Assessment of residual monomer migrating from acrylic polymers and causing Allergic Contact Dermatitis during normal handling and use.
    Pemberton MA; Lohmann BS
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):467-75. PubMed ID: 24859074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemic of Isothiazolinone Allergy in North America: Prevalence Data From the North American Contact Dermatitis Group, 2013-2014.
    Zirwas MJ; Hamann D; Warshaw EM; Maibach HI; Taylor JS; Sasseville D; DeKoven JG; Fransway AF; Mathias CGT; Zug KA; DeLeo VA; Fowler JF; Marks JG; Pratt MD; Belsito DV
    Dermatitis; 2017; 28(3):204-209. PubMed ID: 28509715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.
    Durand G; de Burlet G; Virat M; Nauman BD
    Contact Dermatitis; 2003 Sep; 49(3):148-54. PubMed ID: 14678211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.